Oligonucleotide synthesis market to reach $16.7 billion by 2027
European Pharmaceutical Review
DECEMBER 9, 2022
billion by 2027 during the forecast period, due to the rise in ongoing clinical trials for oligonucleotide-based therapies in key therapeutic sectors such as oncology. The research projected a compound annual growth rate (CAGR) of 16.8 Tag Copenhagen A/S (Denmark). Sarepta Therapeutics, Inc. (US). percent from $7.7
Let's personalize your content